Bloomberg: Schering-Plough Corp. and Merck & Co. may see sales of their cholesterol drug Vytorin drop even further after it was linked to cancer death

``This can't help'' the drug's sales, Gordon Tomaselli, a spokesman for the American Heart Association and a cardiologist at Johns Hopkins University School of Medicine in Baltimore, said in an interview at the European Society of Cardiology conference in Munich today.

Source.